Patent · US Active

2H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor

US11400094B2 · kind B2 · utility

0Cited by

22References

18Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Yam B. Poudel · Fremont, US
Sanjeev Gangwar · Foster City, US
Liqi He · West Chester, US
Prasanna Sivaprakasam · Lawrenceville, US

Key dates

Filing date	Aug 1, 2019
Grant date	Aug 2, 2022
Priority date	—
Expiry date	Jul 11, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds according to formula II are useful as agonists of Toll-like receptor 7 (TLR7).Such compounds can be used in cancer treatment, especially in combination with an anti-cancer immunotherapy agent, or as a vaccine adjuvant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.